GeneDx Ownership | Who Owns GeneDx?
GeneDx Ownership Summary
GeneDx is owned by 56.06% institutional investors, 27.00% insiders, and 16.94% retail investors. Corvex management lp is the largest institutional shareholder, holding 12.00% of WGS shares. ARK Disruptive Innovation Full Composite is the top mutual fund, with 3.06% of its assets in GeneDx shares.
WGS Ownership Benchmark
| Type | Name | % Inst | % Insiders | % Retail |
|---|---|---|---|---|
| Stock | GeneDx | 56.06% | 27.00% | 16.94% |
| Sector | Healthcare Stocks | 35.64% | 12.08% | 52.28% |
| Industry | Healthcare Information Services Stocks | 33.91% | 10.99% | 55.11% |
Institutional Shareholders
Top Institutional Shareholders by Total Shares
| Holder | Shares | % Holding | Value |
|---|---|---|---|
| Corvex management lp | 3.23M | 12.00% | $207.31M |
| Casdin capital | 3.01M | 11.18% | $193.12M |
| Blackrock funding, inc. /de | 1.55M | 5.77% | $99.59M |
| Westfield capital management co lp | 1.37M | 5.09% | $87.92M |
| Goldman sachs group | 1.33M | 4.96% | $85.73M |
| Ark investment management | 1.32M | 4.93% | $85.06M |
| Vanguard group | 1.19M | 4.13% | $154.65M |
| Oracle investment management | 922.45K | 3.23% | $85.15M |
| William blair investment management | 775.27K | 2.88% | $49.79M |
| Zweig-dimenna associates | 689.29K | 2.56% | $44.27M |
Top Institutional Shareholders by % of Total Assets
| Holder | Shares | % Assets | Value |
|---|---|---|---|
| Oracle investment management | 922.45K | 58.40% | $85.15M |
| Casdin capital | 3.01M | 14.62% | $193.12M |
| Alamea verwaltungs gmbh | 185.99K | 8.85% | $11.94M |
| Corvex management lp | 3.23M | 8.24% | $207.31M |
| Gagnon advisors | 148.22K | 7.00% | $9.52M |
| Zweig-dimenna associates | 689.29K | 6.13% | $44.27M |
| Prosight management, lp | 523.46K | 5.51% | $33.62M |
| Gagnon securities | 303.15K | 4.49% | $19.47M |
| Science & technology partners | 241.20K | 4.05% | $15.49M |
| Palisades investment partners | 92.00K | 2.32% | $5.91M |
Top Buyers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Ark investment management | 1.32M | 0.66% | 720.02K |
| Prosight management, lp | 523.46K | 5.51% | 468.46K |
| Citadel advisors | 647.40K | 0.01% | 465.05K |
| Eventide asset management | 459.01K | 0.49% | 459.01K |
| Westfield capital management co lp | 1.37M | 0.37% | 350.85K |
Top Sellers
| Holder | Shares | % Assets | Change |
|---|---|---|---|
| Pentwater capital management lp | 425.00K | 0.26% | -795.00K |
| Fmr | 295.62K | 0.00% | -537.12K |
| T. rowe price investment management | 86.08K | 0.00% | -498.07K |
| Franklin resources | 607.22K | 0.01% | -485.77K |
| Lord, abbett | 42.65K | 0.01% | -475.66K |
New Positions
| Holder | Shares | % Assets | Change | Value |
|---|---|---|---|---|
| Eventide asset management | 459.01K | 0.49% | 459.01K | $29.47M |
| Vestal point capital, lp | 250.00K | 0.45% | 250.00K | $16.05M |
| First light asset management | 242.93K | 1.40% | 242.93K | $15.60M |
| Abrdn | 230.10K | 0.02% | 230.10K | $14.78M |
| Vanguard fiduciary trust | 144.46K | 0.00% | 144.46K | $9.28M |
Sold Out
| Holder | Change |
|---|---|
| Massmutual trust co fsb/adv | -1.00 |
| Assetmark | -1.00 |
| Gps wealth strategies group | -1.00 |
| Mather group, llc. | -2.00 |
| Tortoise investment management | -2.00 |
Institutional Ownership Trends
| Date | Holdings | Change % | Shares | Change % | Ownership | Change % | Increased Position | Change % | Decreased Position | Change % |
|---|---|---|---|---|---|---|---|---|---|---|
| Mar 31, 2026 | 155 | -49.68% | 15,076,123 | -51.36% | 56 | 0.48% | 83 | -45.03% | 49 | -53.33% |
| Dec 31, 2025 | 233 | -19.93% | 20,170,201 | -32.99% | 70 | 0.63% | 118 | -24.36% | 78 | -8.24% |
| Sep 30, 2025 | 282 | 16.53% | 29,207,814 | -0.14% | 102 | 0.98% | 151 | 3.42% | 84 | 50.00% |
| Jun 30, 2025 | 248 | 1.64% | 31,311,682 | 10.33% | 109 | 1.08% | 146 | -0.68% | 60 | -1.64% |
| Mar 31, 2025 | 242 | 15.24% | 28,417,950 | 20.78% | 100 | 1.34% | 144 | -4.64% | 62 | 72.22% |
Top Mutual Funds Shareholders
| Holder | Shares | % Holding | Change |
|---|---|---|---|
| ARK Disruptive Innovation Full Composite | 907.97K | 3.06% | 85.55K |
| ARK Innovation ETF | 907.97K | 3.06% | -1.68K |
| Vanguard Total Stock Mkt Idx Inv | 607.77K | 2.05% | 8.30K |
| iShares Russell 2000 ETF | 526.47K | 1.77% | 3.13K |
| American Funds SMALLCAP World A | 459.49K | 1.55% | 66.34K |
| ARK Genomic Revolution ETF | 455.26K | 1.53% | 13.27K |
| Amova ARK Disruptive Innovation A USD | 428.18K | 1.44% | 58.26K |
| Invesco OFI Small Cap Growth | 395.55K | 1.33% | 35.10K |
| Invesco Discovery A | 395.55K | 1.33% | - |
| ARK Genomic Revolution | 350.20K | 1.18% | 172.18K |
Recent Insider Transactions
| Date | Name | Role | Activity | Value |
|---|---|---|---|---|
| Jun 16, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | $53.08K |
| Jun 16, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | $128.11K |
| Jun 16, 2026 | Feeley Kevin | CHIEF FINANCIAL OFFICER | Sell | $45.41K |
| Jun 16, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | Sell | $127.87K |
| Jun 16, 2026 | Stueland Katherine | CHIEF EXECUTIVE OFFICER | Sell | $360.84K |
Insider Transactions Trends
| Date | Buy | Sell |
|---|---|---|
| 2026 Q2 | 27 | 11 |
| 2026 Q1 | 10 | 38 |
| 2025 Q4 | - | 43 |
| 2025 Q3 | - | 39 |
| 2025 Q2 | 5 | 37 |
WGS Ownership FAQ
Try Tickergate Pro Free
Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)
Customize your own personal stocks lists, views and charts
Choose from hundreds of fields, up to 15 years of history
Conduct deep comparison analysis
Discover trending investment themes
Find your next best investment
Research stocks using tools